The Mandela study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantation Tobias Deuse, Christoph Bara, Markus J. Barten, Stephan W. Hirt, An- dreas O. Doesch, Christoph Knosalla, Carola Grinninger, J¨ org Stypmann, Jens Garbade, Peter Wimmer, Christoph May, Martina Porstner, Uwe Schulz PII: S1551-7144(15)30085-9 DOI: doi: 10.1016/j.cct.2015.09.009 Reference: CONCLI 1275 To appear in: Contemporary Clinical Trials Received date: 22 June 2015 Revised date: 2 September 2015 Accepted date: 4 September 2015 Please cite this article as: Deuse Tobias, Bara Christoph, Barten Markus J., Hirt Stephan W., Doesch Andreas O., Knosalla Christoph, Grinninger Carola, Stypmann J¨ org, Gar- bade Jens, Wimmer Peter, May Christoph, Porstner Martina, Schulz Uwe, The Man- dela study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantation, Contemporary Clinical Trials (2015), doi: 10.1016/j.cct.2015.09.009 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.